Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ’ lung cancer drug Tagrisso backed for first-line use

pharmatimesJuly 12, 2018

Tag: AstraZeneca , NSCLC , Osimertinib

PharmaSources Customer Service